Zeta Biolongevity, Inc. — Form D/A
Zeta Biolongevity, Inc. of AUSTIN, TX, a company, filed a Form D amendment with the SEC on 2018-12-10. The offering totals $2.0M, of which $995K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-12-10
- Form: D/A
- Accession: 0001735987-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $995K
- Remaining: $1.0M
- Minimum investment: $5K
- Investors: 16
- Date of first sale: 2018-03-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-308925
Issuer
- Name: Zeta Biolongevity, Inc.
- CIK: 0001735987
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 4605 GRAY FOX DRIVE, AUSTIN, TX, 78759
- Phone: 5126580921
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Tim Connelly | Director | Austin, TX |
| Randy Thompson | Director | Austin, TX |
| Tim Connelly | Executive Officer | Austin, TX |
| Randy Thompson | Executive Officer | Austin, TX |
Other filings by this issuer (1)
More